Evidence map›Paper›PMID 27894716›Full record

ArticleVaccine2017

Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.

Katherine Schultheis, Hubert Schaefer, Bryan S Yung, Janet Oh, Karuppiah Muthumani, Laurent Humeau, Kate E Broderick, Trevor R F Smith

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Protection againstHuman vaccines & immunotherapeutics · 2020
    Article
  7. Article
  8. Article
  9. A Review of DNA Vaccines Against Influenza.Frontiers in immunology · 2018
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Katherine SchultheisInovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA.
Hubert SchaeferIntracelluar Pathogens, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany.
Bryan S YungInovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA.
Janet OhInovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA.
Karuppiah MuthumaniVaccine Center, The Wistar Institute of Anatomy & Biology, 3601 Spruce St., Philadelphia, PA 19104, USA.
Laurent HumeauInovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA.
Kate E BroderickInovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA.
Trevor R F SmithInovio Pharmaceuticals, Inc., 660W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA. Electronic address: tsmith@inovio.com.
Inovio Pharmaceuticals (United States) · USRobert Koch Institute · DEThe Wistar Institute · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
NCI NIH HHS P30 CA010815
6 · The paper itself

Abstract

The skin is an ideal target tissue for vaccine delivery for a number of reasons. It is highly accessible, and most importantly, enriched in professional antigen presenting cells. Possessing strong similarities to human skin physiology and displaying a defined epidermis, the guinea pig is an appropriate model to study epidermal delivery of vaccine. However, whilst we have characterized the humoral responses in the guinea pig associated with skin vaccine protocols we have yet to investigate the T cell responses. In response to this inadequacy, we developed an IFN-γ ELISpot assay to characterize the cellular immune response in the peripheral blood of guinea pigs. Using a nucleoprotein (NP) influenza pDNA vaccination regimen, we characterized host T cell responses. After delivery of the DNA vaccine to the guinea pig epidermis we detected robust and rapid T cell responses. The levels of IFN-γ spot-forming units averaged approximately 5000 per million cells after two immunizations. These responses were broad in that multiple regions across the NP antigen elicited a T cell response. Interestingly, we identified a number of NP immunodominant T cell epitopes to be conserved across an outbred guinea pig population, a phenomenon which was also observed after immunization with a RSV DNA vaccine. We believe this data enhances our understanding of the cellular immune response elicited to a vaccine in guinea pigs, and globally, will advance the use of this model for vaccine development, especially those targeting skin as a delivery site.

Indexed as

ElectroporationAnimalsEnzyme-Linked Immunospot AssayFemaleGuinea PigsInfluenza VaccinesInterferon-gammaNucleocapsid ProteinsRNA-Binding ProteinsSkinT-LymphocytesVaccines, DNAViral Core ProteinsInfluenza VaccinesInterferon-gammaNP protein, Influenza A virusNucleocapsid ProteinsRNA-Binding ProteinsVaccines, DNAViral Core ProteinsDNA vaccineElectroporationELISpotGuinea pigSkinT cells

Identifiers

PMID27894716
PMCPMC5221502
OpenAlexW2556154585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.